NewAmsterdam Pharma Company N.V. (NAMS) — Business segments and KPIs
Revenue by business segment and geography for NewAmsterdam Pharma Company N.V., with year-over-year trends.
FY 2022
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| License Revenue | 93.50M | 100.0% |